Nicole R. Hadas, SVP, Chief Legal Officer at Akebia Therapeutics, Inc. (AKBA), sold 14,100 shares at $8.70 ($123K) on 2020-02-28, disclosed to the SEC on 2020-03-02.
Open-market sale of $123k AKBA by SVP, Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.70 | 7,050 | $61K | 50.0% |
| 2 | $8.70 | 7,050 | $61K | 50.0% |
| Total | $8.70 avg | 14,100 | $123K | 100% |
| Filing → |
| AKBA | SELL | 2024-02-29 | $11K | — | Filing → |
| AKBA | SELL | 2023-05-25 | $154K | — | Filing → |
| AKBA | SELL | 2023-03-03 | $11K | — | Filing → |